Perspective Therapeutics, Inc.CATXNYSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+86.3%
5Y CAGR+67.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+86.3%/yr
vs +20.3%/yr prior
5Y CAGR
+67.4%/yr
Recent acceleration
Acceleration
+66.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
13.2x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $112.60M | +21.9% |
| 2024 | $92.34M | +117.9% |
| 2023 | $42.38M | +143.2% |
| 2022 | $17.43M | +45.1% |
| 2021 | $12.01M | +40.3% |
| 2020 | $8.56M | -0.5% |
| 2019 | $8.60M | +3.3% |
| 2018 | $8.32M | -2.9% |
| 2017 | $8.57M | +20.0% |
| 2016 | $7.14M | - |